Percentage of blood samples with tenofovir detected (%)
HIV protection efficacy in randomized comparison (%)
Partners PrEP[38]
FTC/TDF arm
81
75
TDF2[37]
79
62
iPrEx[34]
51
44
FEM-PrEP[35]
26
6
Table 2:
Adherence as Evaluated by Blood Concentrations and Efficacy in PrEP Trials.
Goto home»
